Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib.

× No keyword cloud information.

13 in total

1. Diagnosis and management of chronic myelomonocytic leukemia.

Authors: Francesco Onida; Miloslav Beran
Journal: Curr Hematol Malig Rep Date: 2008-01 Impact factor: 3.952

2. PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4.

Authors: Ginny I Chen; Sally Tisayakorn; Claus Jorgensen; Lisa M D'Ambrosio; Marilyn Goudreault; Anne-Claude Gingras
Journal: J Biol Chem Date: 2008-08-20 Impact factor: 5.157

3. Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.

Authors: Chiara Luise; Francesco Merolla; Vincenza Leone; Simona Paladino; Daniela Sarnataro; Alfredo Fusco; Angela Celetti
Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240

4. Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.

Authors: Angeliki Thanasopoulou; Dimitrios J Stravopodis; Konstantinos S Dimas; Juerg Schwaller; Ema Anastasiadou
Journal: PLoS One Date: 2012-02-17 Impact factor: 3.240

5. Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.

Authors: Francesco Merolla; Chiara Luise; Mark T Muller; Roberto Pacelli; Alfredo Fusco; Angela Celetti
Journal: PLoS One Date: 2012-05-24 Impact factor: 3.240

6. FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.

Authors: Francesco Morra; Chiara Luise; Francesco Merolla; Ina Poser; Roberta Visconti; Gennaro Ilardi; Simona Paladino; Hiroyuki Inuzuka; Gianluca Guggino; Roberto Monaco; David Colecchia; Guglielmo Monaco; Aniello Cerrato; Mario Chiariello; Krista Denning; Pier Paolo Claudio; Stefania Staibano; Angela Celetti
Journal: Oncotarget Date: 2015-05-20

Review 7. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Authors: Peter Valent; Attilio Orazi; Michael R Savona; Mrinal M Patnaik; Francesco Onida; Arjan A van de Loosdrecht; Detlef Haase; Torsten Haferlach; Chiara Elena; Lisa Pleyer; Wolfgang Kern; Tea Pemovska; Gregory I Vladimer; Julie Schanz; Alexandra Keller; Michael Lübbert; Thomas Lion; Karl Sotlar; Andreas Reiter; Theo De Witte; Michael Pfeilstöcker; Klaus Geissler; Eric Padron; Michael Deininger; Alberto Orfao; Hans-Peter Horny; Peter L Greenberg; Daniel A Arber; Luca Malcovati; John M Bennett
Journal: Haematologica Date: 2019-05-02 Impact factor: 9.941

8. Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling.

Authors: Fanny Dubois; Franck Vandermoere; Aurélie Gernez; Jane Murphy; Rachel Toth; Shuai Chen; Kathryn M Geraghty; Nick A Morrice; Carol MacKintosh
Journal: Mol Cell Proteomics Date: 2009-08-01 Impact factor: 5.911

9. Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.

Authors: Shilpan Shah; Sanam Loghavi; Guillermo Garcia-Manero; Joseph D Khoury
Journal: J Hematol Oncol Date: 2014-03-27 Impact factor: 17.388

Review 10. The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.

Authors: Aniello Cerrato; Roberta Visconti; Angela Celetti
Journal: Mol Cancer Date: 2018-02-19 Impact factor: 27.401